Cormine

Drug Profile

Cormine

Latest Information Update: 26 Aug 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Anti-ischaemics
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Ischaemic heart disorders

Most Recent Events

  • 23 Feb 1998 A study has been added to the Ischaemic Heart Disease therapeutic trials section
  • 17 Jun 1996 New profile
  • 17 Jun 1996 Investigation in Ischaemic heart disorders in Germany (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top